Korea Pharma & Bio News

home News & Event Korea Pharma & Bio News

No., Title, Writer, Date
No. Title Origin Date
118 Takeda’s drug for acute hereditary angioedema seizure to get larger be... Korea Biomedical Review 2021-02-25
117 Regulator approved 240 generic drugs of Atozet last week Korea Biomedical Review 2021-02-25
116 Boryung to market SN BioScience's nanoparticle anticancer therapy Korea Biomedical Review 2021-02-25
115 Genexine licenses out immunotherapy candidate to Indonesian firm Korea Biomedical Review 2021-02-19
114 HLB's shares tank over alleged public disclosure violation Korea Biomedical Review 2021-02-18
113 Huons finds its treatment under development inhibits coronavirus Korea Biomedical Review 2021-02-18
112 ‘Takeda Pharmaceuticals Korea to leap forward in 2021’ Korea Biomedical Review 2021-02-17
111 US court allows sales resumption of Daewoong's BTX Korea Biomedical Review 2021-02-17
110 inno.N to co-develop ‘global’ anticancer therapy with Voronoi Korea Biomedical Review 2021-02-16
109 Celltrion’s Covid-19 drug weak against South Africa variant Korea Biomedical Review 2021-02-16